Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl + magnesium sulfate versus fentanyl + midazolam for ICU sedation in mechanically ventilated adults
IRCT20160307026950N44Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in None comparing Fentanyl + midazolam with Fentanyl + magnesium sulfate (2 arms). Primary endpoints: Changes in hemodynamic status and Degree of sedation. Started Sep 2022; status: completed.
02
Drugs
fentanylmagnesium sulfatemidazolam
Beyond the preview
Go deeper on IRCT20160307026950N44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N44.